What CVS’s Omnicare sale means for the retail pharmacy giant
The company bought Omnicare for $12.7 billion in 2015 and is selling it for $250 million.
Coverage of the strategies, challenges, and innovations defining the current state of pharmacy M&A in the healthcare space.
The company bought Omnicare for $12.7 billion in 2015 and is selling it for $250 million.
After some will they/won’t they speculation, the sale officially went through on March 6.
After taking a series of economic hits, the retailer is allegedly in talks to sell to PE firm Sycamore Partners.
Shares of CVS Health have dropped about 20% this year, according to reports.
The company spent more than $5 billion to buy the primary care provider just three years ago.
Rosalind Brewer has served as the retail pharmacy giant’s CEO since March 2021.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.